To mitigate the effects of xenogenic GvHD, we repeated this experiment with an identical study design, donor, and production run in the NSG-(KbDb)null (IA)null mouse line, which lacks expression of class I and class II MHC and have reduced incidence of GvHD (Figure S6A).55 The gene discussed is HLA-C; the disease is graft versus host disease.